1. Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment? |
Page:199—202 |
2. Diabetes Nutritional Management for Single-Person Households |
Page:236—240 |
3. Diabetic Patient Social Needs Assessment and Intervention |
Page:241—246 |
4. High-Intensity Interval Training and Diabetes |
Page:224—229 |
5. Sex Differences in Cardiovascular Complications of Type 2 Diabetes |
Page:203—210 |
6. The Impact of Non-Sugar Sweetener on Health Outcomes in the General Population and Patients with Diabetes |
Page:211—216 |
7. Sleep and Diabetes |
Page:217—223 |
8. Latest Approaches in the Treatment of Diabetic Foot Ulcers: An Integrative Analysis Based on the International Working Group on the Diabetic Foot (IWGDF) 2023 Guidelines |
Page:230—235 |
9. Repurposing Antidiabetic Drugs for Rheumatoid Arthritis among an East Asian Population: Results from a Two-Sample Mendelian Randomization Study |
Page:247—253 |
10. Management Strategies for Older Patients with Diabetes Mellitus |
Page:157—164 |
11. Patient Education in Type 2 Diabetes Mellitus through Continuous Glucose Monitoring Reports |
Page:172—176 |
12. Self-Management Experiences of Diabetic Patients in One-Person Household |
Page:184—188 |
13. Management Strategies for Children and Adolescents with Diabetes Mellitus |
Page:145—149 |
14. Management Strategies for Young-Onset Type 2 Diabetes Mellitus: An Integrated Approach |
Page:150—156 |
15. Gut Microbiota and Diabetes |
Page:117—123 |
16. Diabetes and Dietary Proteins-Protein Supplement Intake |
Page:177—183 |
17. Management Strategies for Obese Diabetes |
Page:165—171 |
18. The Effects of Music Therapy on Self-Management, Depression, and Stress in Patients with Type 2 Diabetes Mellitus |
Page:189—198 |
19. Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management |
Page:135—144 |
20. A Position Statement on Diabetes with β-Cell Failure |
Page:124—134 |
21. Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment? |
Page:199—202 |
22. Diabetes Nutritional Management for Single-Person Households |
Page:236—240 |
23. Diabetic Patient Social Needs Assessment and Intervention |
Page:241—246 |
24. High-Intensity Interval Training and Diabetes |
Page:224—229 |
25. Sex Differences in Cardiovascular Complications of Type 2 Diabetes |
Page:203—210 |
26. The Impact of Non-Sugar Sweetener on Health Outcomes in the General Population and Patients with Diabetes |
Page:211—216 |
27. Sleep and Diabetes |
Page:217—223 |
28. Latest Approaches in the Treatment of Diabetic Foot Ulcers: An Integrative Analysis Based on the International Working Group on the Diabetic Foot (IWGDF) 2023 Guidelines |
Page:230—235 |
29. Repurposing Antidiabetic Drugs for Rheumatoid Arthritis among an East Asian Population: Results from a Two-Sample Mendelian Randomization Study |
Page:247—253 |
30. Management Strategies for Older Patients with Diabetes Mellitus |
Page:157—164 |
31. Patient Education in Type 2 Diabetes Mellitus through Continuous Glucose Monitoring Reports |
Page:172—176 |
32. Self-Management Experiences of Diabetic Patients in One-Person Household |
Page:184—188 |
33. Management Strategies for Children and Adolescents with Diabetes Mellitus |
Page:145—149 |
34. Management Strategies for Young-Onset Type 2 Diabetes Mellitus: An Integrated Approach |
Page:150—156 |
35. Gut Microbiota and Diabetes |
Page:117—123 |
36. Diabetes and Dietary Proteins-Protein Supplement Intake |
Page:177—183 |
37. Management Strategies for Obese Diabetes |
Page:165—171 |
38. The Effects of Music Therapy on Self-Management, Depression, and Stress in Patients with Type 2 Diabetes Mellitus |
Page:189—198 |
39. Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management |
Page:135—144 |
40. A Position Statement on Diabetes with β-Cell Failure |
Page:124—134 |
41. Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment? |
Page:199—202 |
42. Diabetes Nutritional Management for Single-Person Households |
Page:236—240 |
43. Diabetic Patient Social Needs Assessment and Intervention |
Page:241—246 |
44. High-Intensity Interval Training and Diabetes |
Page:224—229 |
45. Sex Differences in Cardiovascular Complications of Type 2 Diabetes |
Page:203—210 |
46. The Impact of Non-Sugar Sweetener on Health Outcomes in the General Population and Patients with Diabetes |
Page:211—216 |
47. Sleep and Diabetes |
Page:217—223 |
48. Latest Approaches in the Treatment of Diabetic Foot Ulcers: An Integrative Analysis Based on the International Working Group on the Diabetic Foot (IWGDF) 2023 Guidelines |
Page:230—235 |
49. Repurposing Antidiabetic Drugs for Rheumatoid Arthritis among an East Asian Population: Results from a Two-Sample Mendelian Randomization Study |
Page:247—253 |
50. Management Strategies for Older Patients with Diabetes Mellitus |
Page:157—164 |
51. Patient Education in Type 2 Diabetes Mellitus through Continuous Glucose Monitoring Reports |
Page:172—176 |
52. Self-Management Experiences of Diabetic Patients in One-Person Household |
Page:184—188 |
53. Management Strategies for Children and Adolescents with Diabetes Mellitus |
Page:145—149 |
54. Management Strategies for Young-Onset Type 2 Diabetes Mellitus: An Integrated Approach |
Page:150—156 |
55. Gut Microbiota and Diabetes |
Page:117—123 |
56. Diabetes and Dietary Proteins-Protein Supplement Intake |
Page:177—183 |
57. Management Strategies for Obese Diabetes |
Page:165—171 |
58. The Effects of Music Therapy on Self-Management, Depression, and Stress in Patients with Type 2 Diabetes Mellitus |
Page:189—198 |
59. Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management |
Page:135—144 |
60. A Position Statement on Diabetes with β-Cell Failure |
Page:124—134 |
61. Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment? |
Page:199—202 |
62. Diabetes Nutritional Management for Single-Person Households |
Page:236—240 |
63. Diabetic Patient Social Needs Assessment and Intervention |
Page:241—246 |
64. High-Intensity Interval Training and Diabetes |
Page:224—229 |
65. Sex Differences in Cardiovascular Complications of Type 2 Diabetes |
Page:203—210 |
66. The Impact of Non-Sugar Sweetener on Health Outcomes in the General Population and Patients with Diabetes |
Page:211—216 |
67. Sleep and Diabetes |
Page:217—223 |
68. Latest Approaches in the Treatment of Diabetic Foot Ulcers: An Integrative Analysis Based on the International Working Group on the Diabetic Foot (IWGDF) 2023 Guidelines |
Page:230—235 |
69. Repurposing Antidiabetic Drugs for Rheumatoid Arthritis among an East Asian Population: Results from a Two-Sample Mendelian Randomization Study |
Page:247—253 |
70. Management Strategies for Older Patients with Diabetes Mellitus |
Page:157—164 |
71. Patient Education in Type 2 Diabetes Mellitus through Continuous Glucose Monitoring Reports |
Page:172—176 |
72. Self-Management Experiences of Diabetic Patients in One-Person Household |
Page:184—188 |
73. Management Strategies for Children and Adolescents with Diabetes Mellitus |
Page:145—149 |
74. Management Strategies for Young-Onset Type 2 Diabetes Mellitus: An Integrated Approach |
Page:150—156 |
75. Gut Microbiota and Diabetes |
Page:117—123 |
76. Diabetes and Dietary Proteins-Protein Supplement Intake |
Page:177—183 |
77. Management Strategies for Obese Diabetes |
Page:165—171 |
78. The Effects of Music Therapy on Self-Management, Depression, and Stress in Patients with Type 2 Diabetes Mellitus |
Page:189—198 |
79. Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management |
Page:135—144 |
80. A Position Statement on Diabetes with β-Cell Failure |
Page:124—134 |
81. Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment? |
Page:199—202 |
82. Diabetes Nutritional Management for Single-Person Households |
Page:236—240 |
83. Diabetic Patient Social Needs Assessment and Intervention |
Page:241—246 |
84. High-Intensity Interval Training and Diabetes |
Page:224—229 |
85. Sex Differences in Cardiovascular Complications of Type 2 Diabetes |
Page:203—210 |
86. The Impact of Non-Sugar Sweetener on Health Outcomes in the General Population and Patients with Diabetes |
Page:211—216 |
87. Sleep and Diabetes |
Page:217—223 |
88. Latest Approaches in the Treatment of Diabetic Foot Ulcers: An Integrative Analysis Based on the International Working Group on the Diabetic Foot (IWGDF) 2023 Guidelines |
Page:230—235 |
89. Repurposing Antidiabetic Drugs for Rheumatoid Arthritis among an East Asian Population: Results from a Two-Sample Mendelian Randomization Study |
Page:247—253 |
90. Management Strategies for Older Patients with Diabetes Mellitus |
Page:157—164 |
91. Patient Education in Type 2 Diabetes Mellitus through Continuous Glucose Monitoring Reports |
Page:172—176 |
92. Self-Management Experiences of Diabetic Patients in One-Person Household |
Page:184—188 |
93. Management Strategies for Children and Adolescents with Diabetes Mellitus |
Page:145—149 |
94. Management Strategies for Young-Onset Type 2 Diabetes Mellitus: An Integrated Approach |
Page:150—156 |
95. Gut Microbiota and Diabetes |
Page:117—123 |
96. Diabetes and Dietary Proteins-Protein Supplement Intake |
Page:177—183 |
97. Management Strategies for Obese Diabetes |
Page:165—171 |
98. The Effects of Music Therapy on Self-Management, Depression, and Stress in Patients with Type 2 Diabetes Mellitus |
Page:189—198 |
99. Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management |
Page:135—144 |
100. A Position Statement on Diabetes with β-Cell Failure |
Page:124—134 |
101. 2024 Policy Revision for Support of Type 1 Diabetes Mellitus Patients |
Page:89—92 |
102. Do Type 1 and Type 2 Diabetes Have the Same Vascular Complications? |
Page:62—68 |
103. Technological Innovations Transforming Diabetes Care in Practice |
Page:57—61 |
104. Non-Face-to-Face Diabetes Nutrition Education |
Page:93—98 |
105. A Young Adult’s Life with Diabetes Based on a Social Ecological Model |
Page:99—106 |
106. 2023 Survey Results on the Perception of Diabetes Mellitus among the General Public |
Page:107—116 |
107. Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity |
Page:82—88 |
108. GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide |
Page:76—81 |
109. GLP-1 Receptor Agonist |
Page:69—75 |
110. Discharge Planning for Elderly Diabetic Patients |
Page:52—56 |
111. Management of Early-Onset Type 2 Diabetes |
Page:4—8 |
112. The Global Shortage of Glucagon-Like Peptide-1 Receptor Agonists |
Page:1—3 |
113. Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning |
Page:42—51 |
114. SGLT2 Inhibitors and Diabetes: Where Does It Come from and Where Does It Go? |
Page:9—15 |
115. Prevention of Diabetic Foot and Treatment of Pre-Ulcerative Signs |
Page:35—41 |
116. Chronic Kidney Disease and SGLT2 Inhibitors |
Page:16—25 |
117. SGLT2 Inhibitors in the Cardiovascular Disease |
Page:26—34 |